Snowball logo
logo
JNJ_logo

Johnson & Johnson

$261.62+$0.76ย  (0.29%)
Johnson & Johnson (JNJ) has demonstrated robust fi...
View AAPL example
Estimate
P/E
30.9
EPS
8.48
Beta
0.235
Growth
Revenue, YoY
6.6%
Net income, YoY
-0.05%
Forecast
P/E (FWD)
20.4
EPS (FWD)
12.826
Dividends
Dividend yield
2.05%
Annual payout
$5.36
Next ex. div date
August 25, 26
Payout
46.19%
Div.growth, 5y
4.89%
Dividend growth streak
53 y
Div.rating
About the company
Ticker
JNJ
ISIN
US4781601046
Country
United States of America
Sector (GICS)
Healthcare
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Frequently asked questions

What sector does Johnson & Johnson (JNJ) operate in?

Johnson & Johnson belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Johnson & Johnson (JNJ) current stock price?

As of the latest data, Johnson & Johnson stock price is $261.62, with a previous close of $260.86. Johnson & Johnson gained $0.76 in the last trading session, representing a 0.29% increase.

What is Johnson & Johnson (JNJ) current market capitalization?

Johnson & Johnson market cap is approximately 629.78 billion.

What is Johnson & Johnson (JNJ) Earnings Per Share (EPS)?

The trailing EPS is $8.48, and the forward EPS is $12.83.

What is Johnson & Johnson (JNJ) Price-to-Earnings (P/E) ratio?

Johnson & Johnson current P/E ratio is 30.85, with a forward P/E of 20.4.

What is Johnson & Johnson (JNJ) EBITDA?

Johnson & Johnson EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.17 billion.

Does Johnson & Johnson (JNJ) pay dividends?

Yes. Johnson & Johnson pays quarterly dividends with an annualized yield of 2.05% and an estimated annual payout of $5.36 per share.

When is the next ex-dividend date for Johnson & Johnson (JNJ)?

The next ex-dividend date is scheduled for August 25, 2026.

How did Johnson & Johnson (JNJ) perform in its most recent earnings report?

In the last report (June 30, 2026), Johnson & Johnson posted an EPS surprise of 2.11% and a revenue surprise of 0.99%.

What is Johnson & Johnson (JNJ) beta (volatility) score?

Johnson & Johnson has a beta of 0.235, indicating lower volatility than the overall market.